Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Report Date: February 12, 2026
Reporting Period: Fiscal quarter ended December 31, 2025
Context: The filing announces the issuance of a press release containing financial results for the quarter ended December 31, 2025. The Company is an emerging growth company listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are contained in the referenced Press Release (Exhibit 99.1), which is not included in the input text. Therefore, no specific financial metrics can be extracted from this document.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance or operations compared to prior periods. It only confirms that results for the quarter ended December 31, 2025, have been announced.
Guidance, Outlook, and Risks
Guidance and Outlook: The text does not contain management commentary, forward-looking guidance, or outlook statements.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 12, 2026) for actual revenue, net income, and cash flow figures for the quarter ended December 31, 2025.
- Verify year-over-year and quarter-over-quarter performance metrics in the full press release.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the Company's status as an emerging growth company and any implications for financial reporting standards.